AMISPIC-100
Amikacin Sulphate 100 mg Injection

A sure promise of performance against gram -ve infections
Reduces chances of therapeutic failure ➡ Offers greater resistance to inactivation by bacterial enzyme
Superior Pharmacokinetic Profile
Amikacin alone or associated with either ceftazidime or
piperacillin and tazobactum has shown comparable efficacy & tolerability in the treatment of ICU patients with nosocomial pneumonia
In:
Urogenital Infection
Biliary & intestinal tract Infection Skin and subcutaneous tissues Intra abdominal infections Pneumonia
Bone and joints Infection Bacteraemia & Septicaemias
Respiratory Tract Infection
Burns & Post-Operative Infections